839 hedge funds and large institutions have $12.4B invested in GSK in 2020 Q2 according to their latest regulatory filings, with 90 funds opening new positions, 270 increasing their positions, 320 reducing their positions, and 62 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

more capital invested

Capital invested by funds: $ → $

0.12% less ownership

Funds ownership: 5%4.87% (-0.12%)

16% less repeat investments, than reductions

Existing positions increased: 270 | Existing positions reduced: 320

25% less funds holding in top 10

Funds holding in top 10: 1612 (-4)

Holders
839
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
12
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$94.9M
Puts
$71.7M
Net Calls
Net Calls Change

Top Buyers

1 +$189M
2 +$166M
3 +$84.6M
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$82.7M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$51.3M

Top Sellers

1 -$171M
2 -$158M
3 -$103M
4
Dodge & Cox
Dodge & Cox
California
-$103M
5
Morgan Stanley
Morgan Stanley
New York
-$49.2M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.69B
2
$838M
3
$814M
4
$768M
5
$719M
6
$684M
7
$648M
8
$384M
9
$295M
10
$256M
11
$248M
12
$237M
13
$236M
14
$189M
15
$172M
16
$135M
17
$133M
18
$130M
19
$122M
20
$118M
21
$115M
22
$113M
23
$109M
24
$106M
25
$105M